Radiesse is an injectable called a dermal filler that uses calcium hydroxylapatite
(CaHa), a naturally-occurring substance in the body found in teeth and bones.
Multicentre, prospective, randomized, 52-week trial of calcium hydroxylapatite
Dermal fillers, such as hyaluronic acid (Juvederm, Restylane), calcium hydroxylapatite
(Radiesse), collagen, and even a patient's own fat are used to smooth out wrinkles and add volume to plump up areas such as cheeks and lips.
More viscous fillers such as calcium hydroxylapatite
and poly-L-lactic acid can be difficult to inject through a cannula and require a needle for injection.
As the main inorganic constituent of bone and dental enamel of vertebrates, calcium hydroxylapatite
(HA) has been broadly used in osteoinductive coatings, bone replacement and repair, dental orthopaedics, and so forth [3, 6, 8-11].
Over time the RADIESSE Voice implant carrier gel is resorbed and the Calcium Hydroxylapatite
particles support in-growth of new collagen.
A fine needle injects tiny amounts of hyaluronic acid (or another fillet; like collagen, calcium hydroxylapatite
, or polylactic acid) into deep lines on the face.
They are made up of several types of materials of synthetic, man-made and natural origin, with the most popular ones being collagen-based fillers, poly lactic-based fillers, calcium hydroxylapatite
fillers and hyaluronic acid (HA) fillers.
Two fillers--Radiesse (calcium hydroxylapatite
) and Sculptra (poly-L-lactic acid)--are approved by the Food and Drug Administration to correct facial fat loss in people with HIV.
Combining dermal fillers he uses Radiesse, made of calcium hydroxylapatite
and Restylane made from Hyaluronic acids to restore volume in my face.
Additional filler materials such as calcium hydroxylapatite
(Radiesse) and poly-L-lactic acid (Seulptra) work by adding volume to facial areas that have lost the "fullness of youth." Lasers, chemical peels, and dermabrasion can improve the quality of sun-damaged skin and eradicate scars.
A second endoscopic alternative involves injection of 75to 125-micron particles of calcium hydroxylapatite
. Marketed as Coaptite, this product has recently completed clinical trials and awaits FDA approval, said Dr.